{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:17:28Z","timestamp":1787671048851,"version":"build-2736575974"},"publisher-location":"New York, NY","reference-count":27,"publisher":"Springer US","isbn-type":[{"value":"9781071644294","type":"print"},{"value":"9781071644300","type":"electronic"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/978-1-0716-4430-0_17","type":"book-chapter","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T15:15:57Z","timestamp":1742310957000},"page":"359-375","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Use of Human Acute Myeloid Leukemia Cells to Study Graft-Versus-Leukemia Immunity in Xenogeneic Mouse Models of Graft-Versus-Host Disease"],"prefix":"10.1007","author":[{"given":"Charline","family":"Faville","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"E Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Baron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e9gory","family":"Ehx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,19]]},"reference":[{"issue":"1","key":"17_CR1","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1365-2141.2004.05318.x","volume":"129","author":"C Craddock","year":"2005","unstructured":"Craddock C, Tauro S, Moss P, Grimwade D (2005) Biology and management of relapsed acute myeloid leukaemia. Br J Haematol 129(1):18\u201334. https:\/\/doi.org\/10.1111\/j.1365-2141.2004.05318.x","journal-title":"Br J Haematol"},{"issue":"1\u20132","key":"17_CR2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00281-004-0165-3","volume":"26","author":"F Baron","year":"2004","unstructured":"Baron F, Storb R (2004) Allogeneic hematopoietic cell transplantation as treatment for hematological malignancies: a review. Springer Semin Immunopathol 26(1\u20132):71\u201394","journal-title":"Springer Semin Immunopathol"},{"issue":"12","key":"17_CR3","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1182\/blood.2022016867","volume":"140","author":"H D\u00f6hner","year":"2022","unstructured":"D\u00f6hner H, Wei AH, Appelbaum FR, Craddock C, DiNardo CD, Dombret H, Ebert BL, Fenaux P, Godley LA, Hasserjian RP, Larson RA, Levine RL, Miyazaki Y, Niederwieser D, Ossenkoppele G, R\u00f6llig C, Sierra J, Stein EM, Tallman MS, Tien HF, Wang J, Wierzbowska A, L\u00f6wenberg B (2022) Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood 140(12):1345\u20131377. https:\/\/doi.org\/10.1182\/blood.2022016867","journal-title":"Blood"},{"issue":"7","key":"17_CR4","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/89907","volume":"7","author":"P Fontaine","year":"2001","unstructured":"Fontaine P, Roy-Proulx G, Knafo L, Baron C, Roy DC, Perreault C (2001) Adoptive transfer of minor histocompatibility antigen-specific T lymphocytes eradicates leukemia cells without causing graft-versus-host disease. Nat Med 7(7):789\u2013794. https:\/\/doi.org\/10.1038\/89907","journal-title":"Nat Med"},{"issue":"2","key":"17_CR5","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/bjh.14295","volume":"175","author":"R Zeiser","year":"2016","unstructured":"Zeiser R, Socie G, Blazar BR (2016) Pathogenesis of acute graft-versus-host disease: from intestinal microbiota alterations to donor T cell activation. Br J Haematol 175(2):191\u2013207. https:\/\/doi.org\/10.1111\/bjh.14295","journal-title":"Br J Haematol"},{"issue":"8","key":"17_CR6","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1080\/13543784.2016.1182498","volume":"25","author":"S Servais","year":"2016","unstructured":"Servais S, Beguin Y, Delens L, Ehx G, Fransolet G, Hannon M, Willems E, Humblet-Baron S, Belle L, Baron F (2016) Novel approaches for preventing acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Expert Opin Investig Drugs 25(8):957\u2013972. https:\/\/doi.org\/10.1080\/13543784.2016.1182498","journal-title":"Expert Opin Investig Drugs"},{"issue":"15","key":"17_CR7","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1182\/blood-2012-03-419622","volume":"120","author":"V Grossmann","year":"2012","unstructured":"Grossmann V, Schnittger S, Kohlmann A, Eder C, Roller A, Dicker F, Schmid C, Wendtner C-M, Staib P, Serve H (2012) A novel hierarchical prognostic model of AML solely based on molecular mutations. Blood 120(15):2963\u20132972","journal-title":"Blood"},{"issue":"1","key":"17_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/leu.2016.163","volume":"31","author":"D Rose","year":"2017","unstructured":"Rose D, Haferlach T, Schnittger S, Perglerov\u00e1 K, Kern W, Haferlach C (2017) Subtype-specific patterns of molecular mutations in acute myeloid leukemia. Leukemia 31(1):11\u201317. https:\/\/doi.org\/10.1038\/leu.2016.163","journal-title":"Leukemia"},{"issue":"9","key":"17_CR9","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1056\/NEJMc1608739","volume":"375","author":"E Papaemmanuil","year":"2016","unstructured":"Papaemmanuil E, D\u00f6hner H, Campbell PJ (2016) Genomic classification in acute myeloid leukemia. N Engl J Med 375(9):900\u2013901. https:\/\/doi.org\/10.1056\/NEJMc1608739","journal-title":"N Engl J Med"},{"key":"17_CR10","doi-asserted-by":"publisher","unstructured":"Fisher JN, Kalleda N, Stavropoulou V, Schwaller J (2019) The impact of the cellular origin in acute myeloid leukemia: learning from mouse models. Hema 3(1):e152. https:\/\/doi.org\/10.1097\/hs9.0000000000000152","DOI":"10.1097\/hs9.0000000000000152"},{"issue":"11","key":"17_CR11","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1038\/s41409-021-01363-1","volume":"56","author":"J Courtois","year":"2021","unstructured":"Courtois J, Ritacco C, Dubois S, Canti L, Vandenhove B, Seidel L, Daulne C, Caers J, Servais S, Beguin Y, Ehx G, Baron F (2021) Itacitinib prevents xenogeneic GVHD in humanized mice. Bone Marrow Transplant 56(11):2672\u20132681. https:\/\/doi.org\/10.1038\/s41409-021-01363-1","journal-title":"Bone Marrow Transplant"},{"key":"17_CR12","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.3389\/fimmu.2018.01943","volume":"9","author":"G Ehx","year":"2018","unstructured":"Ehx G, Somja J, Warnatz HJ, Ritacco C, Hannon M, Delens L, Fransolet G, Delvenne P, Muller J, Beguin Y, Lehrach H, Belle L, Humblet-Baron S, Baron F (2018) Xenogeneic graft-versus-host disease in humanized NSG and NSG-HLA-A2\/HHD mice. Front Immunol 9:1943. https:\/\/doi.org\/10.3389\/fimmu.2018.01943","journal-title":"Front Immunol"},{"issue":"2","key":"17_CR13","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/trf.12279","volume":"54","author":"M Hannon","year":"2014","unstructured":"Hannon M, Lechanteur C, Lucas S, Somja J, Seidel L, Belle L, Bruck F, Baudoux E, Giet O, Chantillon AM, Delvenne P, Drion P, Beguin Y, Humblet-Baron S, Baron F (2014) Infusion of clinical-grade enriched regulatory T cells delays experimental xenogeneic graft-versus-host disease. Transfusion 54(2):353\u2013363. https:\/\/doi.org\/10.1111\/trf.12279","journal-title":"Transfusion"},{"key":"17_CR14","doi-asserted-by":"publisher","first-page":"619","DOI":"10.3389\/fimmu.2019.00619","volume":"10","author":"C Gr\u00e9goire","year":"2019","unstructured":"Gr\u00e9goire C, Ritacco C, Hannon M, Seidel L, Delens L, Belle L, Dubois S, V\u00e9riter S, Lechanteur C, Briquet A, Servais S, Ehx G, Beguin Y, Baron F (2019) Comparison of mesenchymal stromal cells from different origins for the treatment of graft-vs.-host-disease in a humanized mouse model. Front Immunol 10:619. https:\/\/doi.org\/10.3389\/fimmu.2019.00619","journal-title":"Front Immunol"},{"issue":"2","key":"17_CR15","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.bbmt.2018.10.007","volume":"25","author":"L Delens","year":"2019","unstructured":"Delens L, Ehx G, Somja J, Vrancken L, Belle L, Seidel L, Gr\u00e9goire C, Fransolet G, Ritacco C, Hannon M, Dubois S, Beguin Y, Baron F, Servais S (2019) In vitro Th17-polarized human CD4(+) T cells exacerbate xenogeneic graft-versus-host disease. Biol Blood Marrow Transplant 25(2):204\u2013215. https:\/\/doi.org\/10.1016\/j.bbmt.2018.10.007","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"17_CR16","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1111\/ajt.16505","volume":"21","author":"G Ehx","year":"2021","unstructured":"Ehx G, Ritacco C, Hannon M, Dubois S, Delens L, Willems E, Servais S, Drion P, Beguin Y, Baron F (2021) Comprehensive analysis of the immunomodulatory effects of rapamycin on human T cells in graft-versus-host disease prophylaxis. Am J Transplant 21(8):2662\u20132674. https:\/\/doi.org\/10.1111\/ajt.16505","journal-title":"Am J Transplant"},{"key":"17_CR17","doi-asserted-by":"publisher","unstructured":"Ehx G, Fransolet G, de Leval L, D'Hondt S, Lucas S, Hannon M, Delens L, Dubois S, Drion P, Beguin Y, Humblet-Baron S, Baron F (2017) Azacytidine prevents experimental xenogeneic graft-versus-host disease without abrogating graft-versus-leukemia effects. Onco Targets Ther 6(5):e1314425. https:\/\/doi.org\/10.1080\/2162402x.2017.1314425","DOI":"10.1080\/2162402x.2017.1314425"},{"issue":"3","key":"17_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.106085","volume":"26","author":"C Ritacco","year":"2023","unstructured":"Ritacco C, K\u00f6se MC, Courtois J, Canti L, Beguin C, Dubois S, Vandenhove B, Servais S, Caers J, Beguin Y, Ehx G, Baron F (2023) Post-transplant cyclophosphamide prevents xenogeneic graft-versus-host disease while depleting proliferating regulatory T cells. iScience 26(3):106085. https:\/\/doi.org\/10.1016\/j.isci.2023.106085","journal-title":"iScience"},{"issue":"4","key":"17_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060680","volume":"8","author":"M von Bonin","year":"2013","unstructured":"von Bonin M, Wermke M, Cosgun KN, Thiede C, Bornhauser M, Wagemaker G, Waskow C (2013) In vivo expansion of co-transplanted T cells impacts on tumor re-initiating activity of human acute myeloid leukemia in NSG mice. PLoS One 8(4):e60680. https:\/\/doi.org\/10.1371\/journal.pone.0060680","journal-title":"PLoS One"},{"issue":"3","key":"17_CR20","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1096\/fj.201800636R","volume":"33","author":"MA Brehm","year":"2019","unstructured":"Brehm MA, Kenney LL, Wiles MV, Low BE, Tisch RM, Burzenski L, Mueller C, Greiner DL, Shultz LD (2019) Lack of acute xenogeneic graft- versus-host disease, but retention of T-cell function following engraftment of human peripheral blood mononuclear cells in NSG mice deficient in MHC class I and II expression. FASEB J 33(3):3137\u20133151. https:\/\/doi.org\/10.1096\/fj.201800636R","journal-title":"FASEB J"},{"issue":"5","key":"17_CR21","doi-asserted-by":"publisher","first-page":"854","DOI":"10.3324\/haematol.2016.153528","volume":"102","author":"AM Paczulla","year":"2017","unstructured":"Paczulla AM, Dirnhofer S, Konantz M, Medinger M, Salih HR, Rothfelder K, Tsakiris DA, Passweg JR, Lundberg P, Lengerke C (2017) Long-term observation reveals high-frequency engraftment of human acute myeloid leukemia in immunodeficient mice. Haematologica 102(5):854\u2013864. https:\/\/doi.org\/10.3324\/haematol.2016.153528","journal-title":"Haematologica"},{"issue":"10","key":"17_CR22","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1038\/leu.2010.158","volume":"24","author":"M Wunderlich","year":"2010","unstructured":"Wunderlich M, Chou FS, Link KA, Mizukawa B, Perry RL, Carroll M, Mulloy JC (2010) AML xenograft efficiency is significantly improved in NOD\/SCID-IL2RG mice constitutively expressing human SCF, GM-CSF and IL-3. Leukemia 24(10):1785\u20131788. https:\/\/doi.org\/10.1038\/leu.2010.158","journal-title":"Leukemia"},{"key":"17_CR23","doi-asserted-by":"publisher","unstructured":"Lopez-Millan B, Diaz de la Guardia R, Roca-Ho H, Anguita E, Islam A, Romero-Moya D, Prieto C, Gutierrez-Ag\u00fcera F, Bejarano-Garcia JA, Perez-Simon JA, Costales P, Rovira M, Mar\u00edn P, Menendez S, Iglesias M, Fuster JL, Urbano-Ispizua A, Anjos-Afonso F, Bueno C, Menendez P (2018) IMiDs mobilize acute myeloid leukemia blasts to peripheral blood through downregulation of CXCR4 but fail to potentiate AraC\/Idarubicin activity in preclinical models of non del5q\/5q- AML. Onco Targets Ther 7(9):e1477460. https:\/\/doi.org\/10.1080\/2162402x.2018.1477460","DOI":"10.1080\/2162402x.2018.1477460"},{"issue":"23","key":"17_CR24","doi-asserted-by":"publisher","first-page":"4842","DOI":"10.1182\/bloodadvances.2020003958","volume":"5","author":"R D\u00edaz de la Guardia","year":"2021","unstructured":"D\u00edaz de la Guardia R, Velasco-Hernandez T, Guti\u00e9rrez-Ag\u00fcera F, Roca-Ho H, Molina O, Nombela-Arrieta C, Bataller A, Fuster JL, Anguita E, Vives S, Zamora L, Nomdedeu J, G\u00f3mez-Casares MT, Ram\u00edrez-Orellana M, Lapillonne H, Ramos-Mejia V, Rodr\u00edguez-Manzaneque JC, Bueno C, Lopez-Millan B, Men\u00e9ndez P (2021) Engraftment characterization of risk-stratified AML in NSGS mice. Blood Adv 5(23):4842\u20134854. https:\/\/doi.org\/10.1182\/bloodadvances.2020003958","journal-title":"Blood Adv"},{"issue":"2","key":"17_CR25","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1080\/14653240601164042","volume":"9","author":"S Vercauteren","year":"2007","unstructured":"Vercauteren S, Zapf R, Sutherland H (2007) Primitive AML progenitors from most CD34(+) patients lack CD33 expression but progenitors from many CD34(\u2212) AML patients express CD33. Cytotherapy 9(2):194\u2013204. https:\/\/doi.org\/10.1080\/14653240601164042","journal-title":"Cytotherapy"},{"issue":"7","key":"17_CR26","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1002\/ijc.32967","volume":"147","author":"N Noronha","year":"2020","unstructured":"Noronha N, Ehx G, Meunier MC, Laverdure JP, Th\u00e9riault C, Perreault C (2020) Major multilevel molecular divergence between THP-1 cells from different biorepositories. Int J Cancer 147(7):2000\u20132006. https:\/\/doi.org\/10.1002\/ijc.32967","journal-title":"Int J Cancer"},{"issue":"1","key":"17_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/cpz1.678","volume":"3","author":"CE Whyte","year":"2023","unstructured":"Whyte CE, Tumes DJ, Liston A, Burton OT (2023) Correction: do more with less: improving high parameter cytometry through overnight staining. Curr Protoc 3(1):e678. https:\/\/doi.org\/10.1002\/cpz1.678","journal-title":"Curr Protoc"}],"container-title":["Methods in Molecular Biology","Graft-Versus-Host Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-4430-0_17","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T15:16:01Z","timestamp":1742310961000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-4430-0_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9781071644294","9781071644300"],"references-count":27,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-4430-0_17","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"19 March 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}